IDSC Expertise Capabilities Services
The Immunotherapies Congress 2013
Farmacoepi Course Leiden 0210 Part 2
Eradicating diseases (genome)
Pre-clinical Development of a Nasal Adenovirus-Based Vaccine Against Ebola Virus (CRTI 06-0218RD) Public Security S&T Symposium 2009.
TB Drug Development Gerald J. Siuta, Ph.D. Business Development May 3, 2007.
ChemAxon's Java Components in a Heterogeneous, Server-Centric Application Environment ChemAxon 2005 User Group Meeting May 19th and 20th, Budapest, Hungary.
Chemaxon's chemo-informatics toolkit integration into the Affectis Data Management System Database Automated Data Integration - Example: IC50 Data generated.
1 dr.Boenjamin Setiawan, Ph.D. Future of Industrial Biotechnology dr.Boenjamin Setiawan, Ph.D.,UCSF 1.Biotechnology consists of Traditional and Modern.
Joseph A. DiMasi, Ph.D. Director of Economic Analysis Tufts Center for the Study of Drug Development Tufts University SLA Pharmaceutical & Health Technology.
ANTICANCER AND ANTI-HIV DRUGS DERIVED FROM AFRICAN AND OTHER PLANTS Gordon Cragg, Ph.D. NIH Special Volunteer Natural Products Branch Developmental Therapeutics.
WHO Expert Working Group on R&D and Financing January 2009 G-FINDER: Global Funding of Innovation for Neglected Diseases.
